Doxorubicin Therapy
Studies from Zagazig University Add New Findings in the Area of Doxorubicin Therapy
Published in Drug Week, October 14th, 2011
"Its long-term use can cause neurodegenerative disorders due to its prolonged activation of microglia. The present study proved that the use of epicatechin prior to DOX treatment significantly attenuated not only the increase in TNF-alpha, iNOS and NF-kappa B expressions but also the increase in TNF-alpha and total nitrite levels in brain tissue when compared with rats treated with DOX-only," wrote R.H. Mohamed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-10-14)
More Articles from Drug Week
- Drug Development
Data from KRIBB Advance Knowledge in Drug Development - Coenzymes
Data from University of California Provide New Insights into Coenzymes - Cancer Therapy
Data on Cancer Therapy Detailed by Researchers at State University of New York - Cancer Therapy
Data on Cancer Therapy Discussed by Researchers at VU University Medical Center - Polyethylene Glycols
Data on Polyethylene Glycols Detailed by L. Sobkow and Co-Authors - Drug Development
Findings from A. Meena and Co-Authors Broaden Understanding of Drug Development - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
